Nauck, M. A. Et Al. 2019. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. DIABETES CARE , vol.42, no.10 , 1912-1920.

Nauck, M. A., Ghorbani, M. L. M., Kreiner, E., Saevereid, H. A., & Buse, J. B., (2019). Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. DIABETES CARE , vol.42, no.10, 1912-1920.

Nauck, Michael Et Al. "Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial," DIABETES CARE , vol.42, no.10, 1912-1920, 2019

Nauck, Michael A. Et Al. "Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial." DIABETES CARE , vol.42, no.10, pp.1912-1920, 2019

Nauck, M. A. Et Al. (2019) . "Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial." DIABETES CARE , vol.42, no.10, pp.1912-1920.

@article{article, author={Michael A. Nauck Et Al. }, title={Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial}, journal={DIABETES CARE}, year=2019, pages={1912-1920} }